| Ticker | ACET |
|---|---|
| ISIN | US0070022076 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for t...
Adicet Bio, Inc opera en el sector Healthcare, industria Biotechnology.